Plasmodium falciparum AMA1 and CSP antigen diversity in parasite isolates from southern Ghana
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Plasmodium falciparum AMA1 and CSP antigen diversity in parasite isolates from southern Ghana. / Kusi, Kwadwo A; Amoah, Linda E; Acquah, Festus Kojo; Ennuson, Nana Aba; Frempong, Abena F; Ofori, Ebenezer A; Akyea-Mensah, Kwadwo; Kyei-Baafour, Eric; Osei, Frank; Frimpong, Augustina; Singh, Susheel K; Theisen, Michael; Remarque, Edmond J; Faber, Bart W; Belmonte, Maria; Ganeshan, Harini; Huang, Jun; Villasante, Eileen; Sedegah, Martha.
I: Frontiers in Cellular and Infection Microbiology, Bind 14, 1375249, 2024.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Plasmodium falciparum AMA1 and CSP antigen diversity in parasite isolates from southern Ghana
AU - Kusi, Kwadwo A
AU - Amoah, Linda E
AU - Acquah, Festus Kojo
AU - Ennuson, Nana Aba
AU - Frempong, Abena F
AU - Ofori, Ebenezer A
AU - Akyea-Mensah, Kwadwo
AU - Kyei-Baafour, Eric
AU - Osei, Frank
AU - Frimpong, Augustina
AU - Singh, Susheel K
AU - Theisen, Michael
AU - Remarque, Edmond J
AU - Faber, Bart W
AU - Belmonte, Maria
AU - Ganeshan, Harini
AU - Huang, Jun
AU - Villasante, Eileen
AU - Sedegah, Martha
N1 - Copyright © 2024 Kusi, Amoah, Acquah, Ennuson, Frempong, Ofori, Akyea-Mensah, Kyei-Baafour, Osei, Frimpong, Singh, Theisen, Remarque, Faber, Belmonte, Ganeshan, Huang, Villasante and Sedegah.
PY - 2024
Y1 - 2024
N2 - INTRODUCTION: Diversity in malarial antigens is an immune evasion mechanism that gives malaria parasites an edge over the host. Immune responses against one variant of a polymorphic antigen are usually not fully effective against other variants due to altered epitopes. This study aimed to evaluate diversity in the Plasmodium falciparum antigens apical membrane antigen 1 (PfAMA1) and circumsporozoite protein (PfCSP) from circulating parasites in a malaria-endemic community in southern Ghana and to determine the effects of polymorphisms on antibody response specificity.METHODS: The study involved 300 subjects, whose P. falciparum infection status was determined by microscopy and PCR. Diversity within the two antigens was evaluated by msp2 gene typing and molecular gene sequencing, while the host plasma levels of antibodies against PfAMA1, PfCSP, and two synthetic 24mer peptides from the conserved central repeat region of PfCSP, were measured by ELISA.RESULTS: Of the 300 subjects, 171 (57%) had P. falciparum infection, with 165 of the 171 (96.5%) being positive for either or both of the msp2 allelic families. Gene sequencing of DNA from 55 clonally infected samples identified a total of 56 non-synonymous single nucleotide polymorphisms (SNPs) for the Pfama1 gene and these resulted in 44 polymorphic positions, including two novel positions (363 and 365). Sequencing of the Pfcsp gene from 69 clonal DNA samples identified 50 non-synonymous SNPs that resulted in 42 polymorphic positions, with half (21) of these polymorphic positions being novel. Of the measured antibodies, only anti-PfCSP antibodies varied considerably between PCR parasite-positive and parasite-negative persons.DISCUSSION: These data confirm the presence of a considerable amount of unique, previously unreported amino acid changes, especially within PfCSP. Drivers for this diversity in the Pfcsp gene do not immediately seem apparent, as immune pressure will be expected to drive a similar level of diversity in the Pfama1 gene.
AB - INTRODUCTION: Diversity in malarial antigens is an immune evasion mechanism that gives malaria parasites an edge over the host. Immune responses against one variant of a polymorphic antigen are usually not fully effective against other variants due to altered epitopes. This study aimed to evaluate diversity in the Plasmodium falciparum antigens apical membrane antigen 1 (PfAMA1) and circumsporozoite protein (PfCSP) from circulating parasites in a malaria-endemic community in southern Ghana and to determine the effects of polymorphisms on antibody response specificity.METHODS: The study involved 300 subjects, whose P. falciparum infection status was determined by microscopy and PCR. Diversity within the two antigens was evaluated by msp2 gene typing and molecular gene sequencing, while the host plasma levels of antibodies against PfAMA1, PfCSP, and two synthetic 24mer peptides from the conserved central repeat region of PfCSP, were measured by ELISA.RESULTS: Of the 300 subjects, 171 (57%) had P. falciparum infection, with 165 of the 171 (96.5%) being positive for either or both of the msp2 allelic families. Gene sequencing of DNA from 55 clonally infected samples identified a total of 56 non-synonymous single nucleotide polymorphisms (SNPs) for the Pfama1 gene and these resulted in 44 polymorphic positions, including two novel positions (363 and 365). Sequencing of the Pfcsp gene from 69 clonal DNA samples identified 50 non-synonymous SNPs that resulted in 42 polymorphic positions, with half (21) of these polymorphic positions being novel. Of the measured antibodies, only anti-PfCSP antibodies varied considerably between PCR parasite-positive and parasite-negative persons.DISCUSSION: These data confirm the presence of a considerable amount of unique, previously unreported amino acid changes, especially within PfCSP. Drivers for this diversity in the Pfcsp gene do not immediately seem apparent, as immune pressure will be expected to drive a similar level of diversity in the Pfama1 gene.
KW - Plasmodium falciparum/genetics
KW - Antigens, Protozoan/genetics
KW - Ghana
KW - Humans
KW - Protozoan Proteins/genetics
KW - Malaria, Falciparum/parasitology
KW - Membrane Proteins/genetics
KW - Antibodies, Protozoan/blood
KW - Female
KW - Adult
KW - Male
KW - Adolescent
KW - Young Adult
KW - Child
KW - Genetic Variation
KW - Child, Preschool
KW - Middle Aged
KW - Sequence Analysis, DNA
KW - Enzyme-Linked Immunosorbent Assay
KW - Polymerase Chain Reaction
KW - Antigenic Variation
KW - DNA, Protozoan/genetics
U2 - 10.3389/fcimb.2024.1375249
DO - 10.3389/fcimb.2024.1375249
M3 - Journal article
C2 - 38808064
VL - 14
JO - Frontiers in Cellular and Infection Microbiology
JF - Frontiers in Cellular and Infection Microbiology
SN - 2235-2988
M1 - 1375249
ER -
ID: 393165288